NSE · ALPA
Alpa Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,785
of 5,072 stocks
▼ 21W
Peak #2,783 · 21 Sep 2026
Alpa Laboratories Limited, a microcap Healthcare business, trades at an undemanding earnings multiple, is seeing revenue slip, and posts a modest return on equity.
Market Cap
124.35 Cr
P/E Ratio
8.81
P/B Ratio
0.67
ROE
8.06%
ROCE
8.94%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 23.93 Cr | 31.40 Cr | 29.05 Cr | 26.26 Cr |
| Net Profit | 98.02 L | 1.38 Cr | 1.90 Cr | 11.24 L |
| EPS | 0.49 | 0.24 | 0.90 | 0.05 |
| Operating Profit | 1.09 Cr | 3.22 Cr | 1.77 Cr | 14.67 L |
Shareholding pattern
Promoter
57.19%
Public
42.81%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 20 Sep 2024 | Other | Annual General Meeting |
| 21 Sep 2023 | Other | Annual General Meeting |
| 20 Sep 2022 | Other | Annual General Meeting |
| 20 Sep 2021 | Other | Annual General Meeting |
| 18 Sep 2020 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.